What Opportunities Are Emerging in Circulating Tumor Cell Diagnostics?

a adăugat un sunet Alte

2026-10-16 19:25:18 - Translate -

The circulating tumor cells market was valued at USD 14.15 billion in 2025, the base year, and is expected to rise to USD 16.08 billion in 2026 before reaching USD 45.13 billion by 2034, registering a CAGR of 13.8% during the forecast period 2026–2034. Growth reflects rising demand for noninvasive cancer diagnostics and expanding use of CTC analysis across clinical and research settings....

0 Commentarii 0 Distribuiri 395 Views 0 previzualizare